These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 137160)

  • 1. Proliferative response of T lymphocytes to allogeneic tumor without generation of killer T lymphocytes in the presence of Ehrlich ascites tumor fluid.
    Laurence JC; Hamaoka T; Kitagawa M
    Gan; 1976 Jun; 67(3):417-23. PubMed ID: 137160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of irradiated and mitomycin-treated mouse spleen cells as stimulating cells in mixed lymphocyte cultures and in vitro sensitization.
    Hodes RJ; Terry WD
    J Immunol; 1974 Jul; 113(1):39-44. PubMed ID: 4275549
    [No Abstract]   [Full Text] [Related]  

  • 3. Killer-helper effect of L cells in the generation of anti-MM cytotoxic T lymphocytes: replacement by beta-interferon and mechanisms of action.
    Ishikawa S; Tachibana T
    Jpn J Cancer Res; 1986 Sep; 77(9):931-40. PubMed ID: 2945807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
    Rouse BT; Röllinghoff M; Warner NL
    Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.
    Ting CC; Rodrigues D
    J Immunol; 1979 Aug; 123(2):801-7. PubMed ID: 156764
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitory effect of tumor-bearing state on the generation of in vivo protective immune T cells in a syngeneic murine tumor system.
    Fujiwara H; Hamaoka T; Nishino Y; Kitagawa M
    Gan; 1977 Oct; 68(5):589-601. PubMed ID: 73490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigens.
    Fujiwara H; Hamaoka T; Teshima K; Aoki H; Kitagawa M
    Immunology; 1976 Aug; 31(2):239-48. PubMed ID: 1085283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol.
    Koren HS; Hodes RJ
    Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages.
    Yang YF; Zou JP; Mu J; Wijesuriya R; Ono S; Walunas T; Bluestone J; Fujiwara H; Hamaoka T
    Cancer Res; 1997 Sep; 57(18):4036-41. PubMed ID: 9307290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
    Belokhvostov AS; Grikurova NK
    Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of lymphocyte and macrophage from mice immunized with Ehrlich ascites tumor cells.
    Sakashita T
    Mie Med J; 1971 Jan; 20(3):227-41. PubMed ID: 5558109
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro recognition of alloantigens: nature of responding and stimulating cells.
    Berman M; Puryear K; Argyris BF
    Cell Immunol; 1976 Apr; 23(1):126-39. PubMed ID: 131649
    [No Abstract]   [Full Text] [Related]  

  • 14. Helper cells in the autologous mixed lymphocyte reaction. I. Generation of cytotoxic T cells recognizing modified self H-2.
    Wolos JA; Smith JB
    J Immunol; 1981 Aug; 127(2):711-5. PubMed ID: 6454726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of cytolytic t lymphocytes in vitro from alloimmune spleen cells.
    Cerottini JC; Engers HD; Fitch FW; Brunner KT
    Transplant Proc; 1976 Sep; 8(3):387-91. PubMed ID: 62429
    [No Abstract]   [Full Text] [Related]  

  • 17. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of protozoan parasites by murine T lymphocytes. II. Role of the H-2 gene complex in interactions between antigen-presenting macrophages and Leishmania-immune T lymphocytes.
    Louis JA; Moedder E; MacDonald HR; Engers HD
    J Immunol; 1981 May; 126(5):1661-6. PubMed ID: 6452473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.
    Burton RC; Chism SE; Warner NL
    J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.